Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

SCOLR Ready To Answer FDA Questions On 12-Hour Pseudoephedrine ANDA

Jan 26 2009

• By Dan Schiff

Related Content

SCOLR Expects New Licensing Agreement This Year

May 14 2007

SCOLR May File NDA For Ibuprofen Product Following Break With Wyeth

Mar 19 2007

Additional Topics

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window